Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease

被引:1
|
作者
Liu, F.
Liang, Z.
Gong, C. X.
机构
[1] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA
[2] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China
关键词
tau phosphorylation; protein phosphatase; Alzheimer disease;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aggregation of abnormal hyperphosphorylated tau to neurofibrillary tangles in affected neurons is one of the hallmarks for Alzheimer disease (AD). Studies during the last decade have strongly suggested that hyperphosphorylation of tau is site-specifically responsible for the loss of biological activity, the gain of toxic activity, and the aggregation into paired helical filaments. Hence, the abnormal hyperphosphorylation of tau appears to be critical to the pathogenesis of AD. The state of tau phosphorylation is controlled by a balance between tau phosphatase(s) activity and tau kinase(s) activity. Many studies have shown that hyperphosphorylation of tau in AD brain might be due to decreased tau phosphatase(s) activity. This article reviews the recent research advances in regulation of tau phosphorylation by phosphoseryl/phosphothreonyl protein phosphatases, and also summarizes the role of each tau phosphatase on abnormal hyperphosphorylation of tau in AD brain.
引用
收藏
页码:97 / 108
页数:12
相关论文
共 50 条
  • [41] Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer's disease
    Borin, Mirta
    Saraceno, Claudia
    Catania, Marcella
    Lorenzetto, Erika
    Pontelli, Valeria
    Paterlini, Anna
    Fostinelli, Silvia
    Avesani, Anna
    Di Fede, Giuseppe
    Zanusso, Gianluigi
    Benussi, Luisa
    Binetti, Giuliano
    Zorzan, Simone
    Ghidoni, Roberta
    Buffelli, Mario
    Bolognin, Silvia
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6
  • [42] ABNORMALLY PHOSPHORYLATED TAU IN ALZHEIMER-DISEASE BRAIN - ROLE OF PHOSPHOPROTEIN PHOSPHATASES
    IQBAL, K
    GONG, CX
    SINGH, TJ
    GRUNDKEIQBAL, I
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (03): : 266 - 266
  • [43] Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease
    D'Ambrosio, C
    Arena, S
    Fulcoli, G
    Scheinfeld, MH
    Zhou, DW
    D'Adamio, L
    Scaloni, A
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (01) : 97 - 113
  • [44] Targeting Tau Protein in Alzheimer’s Disease
    Cheng-Xin Gong
    Inge Grundke-Iqbal
    Khalid Iqbal
    Drugs & Aging, 2010, 27 : 351 - 365
  • [45] Alzheimer's disease:: β-amyloid protein and tau
    Morishima-Kawashima, M
    Hara, Y
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 392 - 401
  • [46] Targeting Tau Protein in Alzheimer's Disease
    Gong, Cheng-Xin
    Grundke-Iqbal, Inge
    Iqbal, Khalid
    DRUGS & AGING, 2010, 27 (05) : 351 - 365
  • [47] Tau Protein Associated Inhibitors in Alzheimer Disease
    Li, Qian-Qian
    Chu, Ting-Ting
    Chen, Yong-Xiang
    Li, Yan-Mei
    CHINESE JOURNAL OF CHEMISTRY, 2014, 32 (10) : 964 - 968
  • [48] Targeting tau protein in Alzheimer's disease
    Rafii, Michael S.
    LANCET, 2016, 388 (10062): : 2842 - 2844
  • [49] Hyperphosphorylation of tau protein indicates Alzheimer-like axonal degeneration in superficial CNS siderosis
    Kondziella, D.
    Zetterberg, H.
    JOURNAL OF NEUROLOGY, 2008, 255 : 157 - 157
  • [50] Rosiglitazone ameliorate Alzheimer-like hyperphosphorylation of tau protein in the hippocampus of rats with insulin resistance
    Hu Shu-Hong
    Yang Yan
    Zhang Jian-Hua
    Zhang Mu-Xun
    Gong Cheng-Xin
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2007, 34 (05) : 533 - 537